STAY AHEAD WITH
CLEARER SKIN AND LESS ITCH

DUPIXENT in combination with a topical corticosteroid was studied in a 16-week clinical trial in 162
patients ages 6 months to 5 years with moderate-to-severe eczema not adequately controlled with topical
prescription treatments.

 

Dupixent results
in young children

From a clinical trial at 16 weeks (DUPIXENT + topical corticosteroids [TCS] vs TCS only):

7X
SAW CLEAR OR
ALMOST CLEAR SKIN

28% on DUPIXENT + TCS
vs 4% on TCS only

~5X
HAD LESS ITCH

48% on DUPIXENT + TCS
vs 9% on TCS only

≥75%
Clearer skin in
half
of young
children

53% on DUPIXENT + TCS vs 11% on TCS only

View BEFORE AND AFTER
Photos IN YOUNG CHILDREN

 

Click and drag
to see results dragging icon

Before
Treatment

AFTER TREATMENT
With
DUPIXENT at
16 Weeks

Actual 4-year-old clinical trial patient treated with DUPIXENT and a topical corticosteroid. This patient met clinical trial criteria for clear or almost clear skin. Individual results may vary.

LONG-TERM
SAFETY RESULTS IN YOUNG CHILDREN

Long-term safety results in young children continuing on DUPIXENT with or without TCS in the pediatric extension study through 1 year were consistent with the adult clinical trials. In addition, hand-foot-and-mouth disease and warts were reported. In these reported cases, patients continued treatment with DUPIXENT.

MOST COMMON SIDE
EFFECTS INCLUDE:

  • Injection site reactions
  • Eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision
  • Dry eye
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

View the possible side effects of DUPIXENT

What You Should Know About the Patients in THIS STUDY:

100%
Had moderate-to-severe
atopic dermatitis
~3.8 years
Average age
~58%
Average body surface area involvement

Have you spoken to a dermatologist or allergist about DUPIXENT?

Go back

Great! Sign up for DUPIXENT MyWay®, our patient support program, to access program benefits and get one-on-one support every step of the way, including help with filling your first prescription.

Enroll in DUPIXENT MyWay

If you’re still struggling with moderate-to-severe eczema, maybe it’s time to change the conversation.

WATCH A VIDEO ON ASKING ABOUT DUPIXENT

Answer a few short questions about your eczema symptoms and treatment goals. We’ll turn it into a personalized guide you can use at your next visit.

Get Started

Specialists like dermatologists or allergists often have more experience treating moderate-to-severe eczema and can help create a personalized care plan for you.

Find a Specialist Near Me
DID YOU KNOW?
DUPIXENT is the only FDA-approved biologic for treating uncontrolled
moderate-to-severe eczema in children as young as 6 months.